| BTC | basal temperature chart; body temperature chart |
|---|---|
| RT | radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti... |
| STP | phenol-preferring sulfotransferase; scientifically treated petroleum; sodium thiopental; standard te... |
| Tm | melting temperature; temperature midpoint; tubular maximum excretory capacity of kidneys |
| TP | temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t... |
mouth to mask breathing
| newborn | neonatal, neonate |
|---|---|
| newborn jaundice | <paediatrics> A normal condition of elevated bilirubin in the bloodstream of a newborn. This occurs secondary to immaturity of liver cells (cannot effectively metabolise bilirubin) and the increased destruction of red blood cells (further releasing bilirubin into the bloodstream) that is normally seen in the newborn. The jaundice usually appears between the 2nd and 5th days of life and usually clears by 2 weeks. Other factors which can potentiate jaundice in the newborn include: sepsis, biliary atresia, Rhesus incompatibility, galactosaemia, cephalohaematoma, polycythaemia, G-6-P-D deficiency and congenital rubella, syphilis, toxoplasmosis or cytomegalovirus infection. (10 Jan 1998) |
| newborn screening | Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism. (12 Dec 1998) |
| subcutaneous fat necrosis of newborn | Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum. (05 Mar 2000) |
| disease, haemolytic, of the newborn | Abnormal breakup of red blood cells in the foetus or newborn. (12 Dec 1998) |
| infant, newborn | An infant during the first month after birth. (12 Dec 1998) |
| infant, newborn, diseases | Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both hereditary diseases and metabolism, inborn errors are available as general concepts. (12 Dec 1998) |
| jaundice of the newborn | Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system. Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice. (05 Mar 2000) |
| leukocytosis of the newborn | An apparently "physiologic" leukocytosis usually observed in newborn infants, in whom the white blood cell counts are usually greater than 10,000 per cu mm, and sometimes range to 45,000 per cu mm, resulting chiefly from increased numbers of neutrophils (especially single and bilobed forms). On the third or fourth day of life, the count generally decreases rapidly, and then fluctuates for several days; beginning about the fourth week of life, a relative lymphocytosis is observed, and this normally continues for a few years. (05 Mar 2000) |
| appetite regulation | Physiologic mechanisms which regulate or control the appetite and food intake. (12 Dec 1998) |
| gene expression regulation | Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action at the level of transcription or translation. These processes include gene activation and genetic induction. (12 Dec 1998) |
| gene expression regulation, archaeal | Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in archaea. (12 Dec 1998) |
| gene expression regulation, bacterial | Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. (12 Dec 1998) |
| gene expression regulation, developmental | Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism. (12 Dec 1998) |
| gene expression regulation, enzymologic | Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. (12 Dec 1998) |